{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "San Diego",
      "address_1": "3985 Sorrento Valley Blvd Ste B",
      "reason_for_recall": "Accumetrics is recalling the VerifyNow IIb/IIIa 10-Test because it contains incorrect information for the amount of time in which to perform the test following collection of the patient sample.  The correct instruction is to perform the test within 15 minutes of collecting the patient sample.",
      "address_2": "",
      "product_quantity": "69 units",
      "code_info": "Lot No. WC0181H, WC0181J, WC0181K",
      "center_classification_date": "20131211",
      "distribution_pattern": "Nationwide Distribution including  NY, PA, DC, CT, IN, NJ, AR, TX, AZ,and NM.",
      "state": "CA",
      "product_description": "VerifyNow IIb/IIIa Test, 10-Test Kit, Catalog No. 85310,    10 tests/box; 690 total tests.    The VerifyNow IIb/IlIa Test is a semi-quantitative, whole blood platelet function test used to measure glycoprotein (GP) lIb/IlIa receptor blockade in patients treated with abciximab or eptifibatide. VerifyNow lIb/IlIa Test results should be interpreted in conjunction with other clinical and laboratory data available to the clinician. The VerifyNow System is a turbidimetric based optical detection system which measures platelet-induced aggregation. The system consists of an instrument, a disposable test device and quality control materials. The VerifyNow lIb/IlIa Test is a semi-quantitative, whole blood platelet function test used to measure glycoprotein (GP) lIb/IlIa receptor blockade in patients treated with abciximab or eptifibatide.",
      "report_date": "20131218",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Accumetrics Inc",
      "recall_number": "Z-0482-2014",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "66834",
      "termination_date": "20131223",
      "more_code_info": "",
      "recall_initiation_date": "20131114",
      "postal_code": "92121-1497",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}